TriLink BioTechnologies Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
329
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
3
TriLink BioTechnologies General Information
Description
Developer of modified nucleic acids intended for the synthesis of nucleic acids, NTPs and mRNA capping analogs. The company provides custom oligonucleotides, nucleoside triphosphates and synthesis reagents for research and diagnostic laboratories as well as offers radio-labeling services, custom chemistry and contract research services for oligos and small molecules.
Contact Information
Website
www.trilinkbiotech.com(Operating Subsidiary)
Corporate Office
- 10770 Wateridge Circle
- Suite 200
- San Diego, CA 92121
- United States
Corporate Office
- 10770 Wateridge Circle
- Suite 200
- San Diego, CA 92121
- United States
TriLink BioTechnologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TriLink BioTechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TriLink BioTechnologies Patents
TriLink BioTechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023213852-A1 | Trinucleotide cap analogs and methods of use thereof | Pending | 27-Jan-2022 | ||
| EP-4469465-A1 | Trinucleotide cap analogs and methods of use thereof | Pending | 27-Jan-2022 | ||
| US-20250108066-A1 | Trinucleotide cap analogs and methods of use thereof | Pending | 27-Jan-2022 | ||
| AU-2016328645-B2 | Compositions and methods for synthesizing 5'-capped rnas | Active | 21-Sep-2015 | ||
| AU-2016328645-C1 | Compositions and methods for synthesizing 5'-capped rnas | Active | 21-Sep-2015 | C07H21/02 |
TriLink BioTechnologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TriLink BioTechnologies Investments & Acquisitions (3)
TriLink BioTechnologies’s most recent deal was a Merger/Acquisition with MyChem for . The deal was made on 28-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MyChem | 28-Jan-2022 | Merger/Acquisition | Specialty Chemicals | ||
| Solulink | 01-Feb-2017 | Merger/Acquisition | Biotechnology | ||
| Solulink | 28-Feb-2008 | Early Stage VC | Biotechnology |
TriLink BioTechnologies Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| MyChem | San Diego, CA | 2007 |
TriLink BioTechnologies FAQs
-
When was TriLink BioTechnologies founded?
TriLink BioTechnologies was founded in 1996.
-
Where is TriLink BioTechnologies headquartered?
TriLink BioTechnologies is headquartered in San Diego, CA.
-
What is the size of TriLink BioTechnologies?
TriLink BioTechnologies has 329 total employees.
-
What industry is TriLink BioTechnologies in?
TriLink BioTechnologies’s primary industry is Biotechnology.
-
Is TriLink BioTechnologies a private or public company?
TriLink BioTechnologies is a Private company.
-
What is TriLink BioTechnologies’s current revenue?
The current revenue for TriLink BioTechnologies is .
-
When was TriLink BioTechnologies acquired?
TriLink BioTechnologies was acquired on 06-Sep-2016.
-
Who acquired TriLink BioTechnologies?
TriLink BioTechnologies was acquired by Maravai LifeSciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
